Publications

Related Pages

The bibliography below contains selected publications produced by members of the EIP Network since 2012. It is arranged by topic, with citations listed chronologically.

  • Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, Thomas A, Harrison LH, Nichols M, Petit S, Miller L, Moore MR, Schrag SJ, Lessa FC, Skoff TH, MacNeil JR, Briere EC, Weston EJ, Van Beneden C. Twenty Years of Active Bacterial Core Surveillance. Emerg Infect Dis. 2015 Sep;21(9):1520-8
  • Langley G, Besser J, Iwamoto M, Lessa FC, Cronquist A, Skoff TH, Chaves S, Boxrud D, Pinner RW, Harrison LH. Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance. Emerging Infectious Dis. 2015 Sep;21(9):1582-8.

ABCs Other

  • Fridkin SK, Cleveland AA, See I, Lynfield R. Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance. Emerg Infect Dis. 2015;21(9):1578-81. doi: 10.3201/eid2109.150512.
  • Hadler JL, Vugia DJ, Bennett NM, Moore MR. Emerging Infections Program Efforts to Address Health Equity. Emerg Infect Dis. 2015;21(9):1589-94. doi: 10.3201/eid2109.150275.
  • Hadler JL, Danila RN, Cieslak PR, et al. Emerging Infections Program–State Health Department Perspective. Emerg Infect Dis. 2015;21(9):1510-5. doi: 10.3201/eid2109.150428.
  • Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, Thomas A, Harrison LH, Nichols M, Petit S, Miller L, Moore MR, Schrag SJ, Lessa FC, Skoff TH, MacNeil JR, Briere EC, Weston EJ, Van Beneden C. Twenty Years of Active Bacterial Core Surveillance. Emerg Infect Dis 2015; 21(9):1520-8.
  • Langley G, Besser J, Iwamoto M, Lessa, Cronquist, Skoff, Chaves, Boxrud, Pinner, Harrision. Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance. Emerg Infect Dis. 2015;21(9):1582-8. doi: 10.3201/eid2109.150570
  • Lynfield R, Schaffner W. Emerging Infections Program–20 Years of Achievements and Future Prospects. Emerg Infect Dis. 2015;21(9):1497-8. doi: 10.3201/eid2109.150564.
  • Pinner RW, Lynfield R, Hadler JL, et al. Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections. Emerg Infect Dis. 2015;21(9):1499-509. doi: 10.3201/eid2109.150619.
  • Vugia DJ, Meek JI, Danila RN, et al. Training in Infectious Disease Epidemiology through the Emerging Infections Program Sites. Emerg Infect Dis. 2015;21(9):1516-9. doi: 10.3201/eid2109.150443.
  • Olsen R, Fittipalide N, Kachroo P, Sanson M, Long S, Como-Sabetti K, Valson C, Cantu C, Lynfield R, Van Beneden C, Beres S, Musser J.  Clinical Laboratory Response to a Mock Outbreak of Invasive Bacterial Infections: A Preparedness Study. J Clin Microbiol 2014; 2(12):4210-16.
  • Srinivasan V, Metcalf BJ, Knipe KM, Ouattara M, McGee L, Shewmaker PL, Glennen A, Nichols M, Harris C, Brimmage M, Ostrowsky B, Park CJ, Schrag SJ, Frace MA, Sammons SA, Beall B. vanG element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosus.External MBio. 2014 Jul 22;5(4):e01386-14.
  • Whitney, C. G., F. Zhou, J. Singleton, A. Schuchat, Control Centers for Disease, and Prevention. Benefits from Immunization During the Vaccines for Children Program Era – United States, 1994-2013. MMWR Morb Mortal Wkly Rep 63, no. 16 (Apr 25 2014): 352-5.
  • Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Atlanta, GA: US Department of Health and Human Services, CDC; 2013.
  • Dawood FS, Chaves SS, Pérez A, Reingold A, Meek J, Farley MM, Ryan P, Lynfield R, Morin C, Baumbach J, Bennett NM, Zansky S, Thomas A, Lindegren ML, Schaffner W, Finelli L; for the Emerging Infections Program Network. Complications and associated bacterial co-infections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010.External J Infect Dis. 2013 Aug 28. [Epub ahead of print].

Group A Streptococcus

  • Lindegren ML, McCormack L, Barnes B, Mitchel E, Jones S, Schaffner W. Assessment of Administrative Medical Claims Data for Public Health Surveillance of Invasive Group A Streptococcal Necrotizing Faciitis in Tennessee.  Public Health Rep. 2016 Jul-Aug; 131(4):560-5.
  • Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfield R, Aragon D, Zansky SM, Watt JP, Cieslak PR, Angeles K, Harrison LH, Petit S, Beall B, Van Beneden CA. Epidemiology of Invasive Group A Streptococcal Infections in the United States 2005-2012. Clin Infectious Dis 2016, doi: 10.1093/cid/ciw248
  • Langley G, Hao Y, Pondo T, Miller L, Petit S, Thomas A, Lindegren ML, Farley MM, Dumyati G, Como-Sabetti K, Harrison LH, Baumbach J, Watt J, Van Beneden C. The Impact of Obesity and Diabetes on the Risk of Disease and Death due to Invasive Group A Streptococcus Infections in Adults. Clin Infect Dis. (2015); doi: 10.1093/cid/civ1032
  • Zhu L, Olsen RJ, Nasser W, Beres SB, Vuopio J, Kristinsson KG, Gottfredsson M, Porter AR, DeLeo FR, Musser JM.  A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Invest. 2015;125(9):3545–3559. doi:10.1172/JCI82478.
  • Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Wesley Long S, Kristinsson KG, Gottfredsson M, Vuopio J, Raisanen K, Caugant DA, Steinbakk M, Low DE, McGeer A, Darenberg J, Henriques-Normark B, Van Beneden CA, Hoffmann S, Musser JM. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci 2014.14;111(17):E1768-76. Epub 2014 Apr 14.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2013.
  • Dooling KL, Crist MB, Nguyen DB, Bass J, Lorentzson L, Toews KA, Pondo T, Stone ND, Beall B, Van Beneden C. Investigation of a prolonged group a streptococcal outbreak among residents of a skilled nursing facility, Georgia, 2009-2012. Clin Infect Dis. 2013 Dec;57(11):1562-7. Epub 2013 Sep 9.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2012.
  • Fittipaldi N, Olsen RJ, Beres SB, Van Beneden C, Musser JM. Genomic analysis of emm59 group A Streptococcus invasive strains, United States. Emerg Infect Dis 2012;18(4):650-2.
  • Olsen RJ, Laucirica DR, Watkins ME, Feske ML, Garcia-Bustillos JR,Vu C,Cantu C, Shelburne SA 3rd,Fittipaldi N. Kumaraswami M, Shea PR, Flores AR, Beres SB, Lovgren M, Tyrrell GJ, Efstratiou A, Low DE, Van Beneden C, Musser JM. Polymorphisms in Regulator of Protease B (RopB) Alter Disease Phenotype and Strain Virulence of Serotype M3 Group A Streptococcus. J Infect Dis 2012; 205(11):1719-29.

Group B Streptococcus

Haemophilus influenzae

  • Blain A, MacNeil J, Wang X, Bennett N, Farley MM, Harrison LH, Lexau C, Miller L, Nichols M, Petit S, Reingold A, Schaffner W, Thomas A, Clark T, Cohn A, Briere E. Invasive Haemophilus influenzae Disease in Adults ≥65 Years, United States, 2011. Open Forum Infect Dis. 2014; 1(2): ofu044. doi: 10.1093/ofid/ofu044. eCollection 2014 Sep.
  • Briere EC, Rubin L, Moro PL, Cohn A, Clark T, Messonnier N. Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 2014; 63(RR01):1-14.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2013.
  • Anderson R, Wang X, Briere EC, Katz LS, Cohn AC, Clark TA, Messonnier NE, Mayer LW. Haemophilus haemolyticus isolates causing clinical disease. J Clin Microbiol. 2012 Jul; 50(7): 2462-5.
  • Briere EC, Jackson M, Shah SG, Cohn AC, Anderson RD, MacNeil JR, Coronado FM, Mayer LW, Clark TA, Messonnier NE. Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009. Pediatrics 2012; 130(3):414-20.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2012.
  • Jackson ML, Rose CE, Cohn A, Coronado F, Clark TA, Wenger JD, Bulkow L, Bruce MG, Messonnier NE, Hennessy TW. Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs. Emerg Infect Dis 2012;18:13-20.
  • Livorsi DJ, MacNeil JR, Cohn AC, Bareta J, Zansky S, Petit S, Gershman K, Harrison LH, Lynfield R, Reingold A, Schaffner W, Thomas A, Farley MM. Invasive Haemophilus influenzae in the United States, 1999-2008: Epidemiology and Outcomes. J Infect 2012 Dec; 65(6):496-504.
  • Lowther SA, Shinoda N, Juni BA, Theodore MJ, Wang X, Jawahir SL, Jackson ML, Cohn A, Danila R, Lynfield R. Haemophilus influenzae type b infection, vaccination, and influenzae carriage in children in Minnesota, 2008-2009. Epidemiol Infect. March 2012;140(3):566-74.
  • Theodore MJ, Anderson RD, Wang X, Katz LS, Vuong JT, Bell ME, Juni BA, Lowther SA, Lynfield R, MacNeil JR, Mayer LW. Evaluation of new biomarker genes for differentiating Haemophilus influenzae from Haemophilus haemolyticus. J Clin Microbiol 2012; 50(4): 1422-24.

Legionellosis

Methicillin-resistant Staphylococcus aureus (MRSA)

Pertussis

  • McNamara, L, Skoff, T, Faulkner A, Miller L, Kudish K, Kenyon C, Bargsten M, Zansky S, Sullivan A, Martin S, Briere E. Reduced severity of pertussis in persons with age-appropriate pertussis vaccination — United States, 2010–2012. (Accepted to CID 2017).
  • Weigand M, Peng Y, Loparev V, et al. The history of Bordetella pertussis genome plasticity and conserved rearrangement. (Accepted to Journal of Bacteriology).
  • Cassiday PK, Skoff TH, Jawahir S, Tondella ML. Changes in the predominance of pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates, United States, 2000-2012. Emerging Infect Dis. 2016 March 22(3):442-8.
  • Williams MM, Sen K, Weigand MR, et al. Bordetella pertussis strain lacking pertactin and pertussis toxin. Emerg Infect Dis. 2016 Feb;22(2):319-22.
  • Skoff TH, Kenyon C, Cocoros N, Liko J, Miller L, Kudish K, Baumbach J, Zansky S, Faulkner A, Martin SW. Sources of infant pertussis infection in the United States. Pediatrics. 2015 Oct; 136(4):635-41.
  • Skoff TH, Baumbach J, Cieslak PR. Tracking pertussis and evaluating control measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States. Emerging Infect Dis. 2015 Sep;21(9):1568-73.
  • Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, Reynolds L, Kenyon C, Giambrone G, Kudish K, Miller L, Selvage D, Lee A, Skoff TH, Kamiya H, Cassiday PK, Tondella ML, Clark TA. Pertactin-negative Bordetella pertussis strains: Evidence for a possible selective advantage. Clin Infect Dis. 2015 Jan 15;60(20):223-7.
  • Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison M, Shang W, Williams MM, Bowden KE, Burgos-Rivera B, Qin X, Messonnier N, Tondella ML. Prevalence and molecular characterization of pertactin-decficient Bordetella pertussis in the US. Clin Vaccine Immunol. 2014 Feb;21(2):119-25.

Pneumococcal disease

  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance, Emerging Infections Program Network, Trends by Serotype Group – Streptococcus pneumoniae, 1998-2015.
  • Link-Gelles R, Westreich D, Aiello AE, Shang N, Weber DJ, Holtzman C, Scherzinger K, Reingold A, Schaffner W, Harrison LH, Rosen JB, Petit S, Farley M, Thomas A, Eason J, Wigen J, Barnes M, Thomas O, Zansky S, Beall B, Whitney CG, Moore MR. Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study.External  SSM-Population Health. 2016 Dec; 2: 587-594.
  • Metcalf BJ, Chochua S, Gertz RE Jr, Li Z, Walker H, Tran T, Hawkins PA, Glennen A, Lynfield R, Li Y, McGee L, Beall B; Active Bacterial Core surveillance team. Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States.External Clin Microbiol Infect. 2016 Aug 16. pii: S1198-743X(16)30302-0
  • Kim L., McGee L, Tomczyk S, Beall B. Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in pre- and post-Conjugate Vaccine eras: a United States Perspective. Clin Microbiol Rev. 2016 Jul;29(3):525-52.
  • Li Y, Metcalf BJ, Chochua S, Li Z, Gertz RD, Walker H, Hawkins PA, Tran T, Whitney CG, McGee L, Beall B, on behalf of Active Bacterial Core surveillance team. Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in Streptococcus pneumoniae. 2016 May-Jun; 7(3): e00765-16.
  • Nichols MC, Bareta J, Coyle A, Landen M. Using Hospital Inpatient Discharge Data to Supplement Active Surveillance for Invasive Pneumococcal Disease: Is Extract Worth the Exertion? Public Health Rep. 2016 May-Jun; 131(3):404-10.
  • De St Maurice A, Schaffner W, Griffin MR, Halasa N, Grijalva CG. Persistent gender disparities in invasive pneumococcal diseases in the conjugate era. J Infect Dis. 2016 May 30. [Epub].
  • Matthew R. Moore, Ruth Link-Gelles, William Schaffner, Ruth Lynfield, Corinne Holtzman, Lee H. Harrison, Shelley M. Zansky, Jennifer B. Rosen, Arthur Reingold, Karen Scherzinger, Ann Thomas, Ramon E. Guevara, Tasneem Motala, Jeffrey Eason, Meghan Barnes, Susan Petit, Monica Farley, Lesley McGee, James H. Jorgensen, Cynthia G. Whitney. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study. Lancet Resp Med. 2016. [in press]
  • Metcalf BJ, Gertz RE Jr, Gladstone RA, Walker H, Sherwood LK, Jackson D, Li Z, Hawkins PA, Chochua S, Sheth M, Rayamajhi N, Bentley SD, Kim L, Whitney CG, McGee L, Beall B; Active Bacterial Core surveillance team. Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA.External Clin Microbiol Infect. 2016 Jan; 22(1); 60. E9-60.
  • Moore MR, Whitney CG. Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 years of the Emerging Infections Program. Emerg Infect Dis. 2015 Sep;21(9):1551-6.
  • Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, Pilishvili T. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 2015; 64(34);944-947.
  • Hawkins PA, Chochua S, Jackson D, Beall B, McGee L. Mobile Elements and Chromosomal Changes Associated with MLS Resistance Phenotypes of Invasive Pneumococci Recovered in the United States.External Microb Drug Resist. 2015 Apr;21(2):121-9.
  • Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, Miller L, Scherzinger K, Thomas A, Farley MM, Zell ER, Taylor TH Jr, Pondo T, Rodgers L, McGee L, Beall B, Jorgensen JH, Whitney CG. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.External Lancet Infect Dis. 2015;15:301-9.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2014.
  • Croucher NJ, Hanage WP, Harris SR, McGee L, van der Linden M, de Lencastre H, Sá-Leão R, Song JH, Ko KS, Beall B, Klugman KP, Parkhill J, Tomasz A, Kristinsson KG, Bentley SD. Variable recombination dynamics during the emergence, transmission and ‘disarming’ of a multidrug-resistant pneumococcal clone.External BMC Biol. 2014 Jun 23;12:49.
  • Croucher NJ, Chewapreecha C, Hanage WP, Harris SR, McGee L, van der Linden M, Song JH, Ko KS, de Lencastre H, Turner C, Yang F, Sá-Leão R, Beall B, Klugman KP, Parkhill J, Turner P, Bentley SD. Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.External Genome Biol Evol. 2014 Jun 10;6(7):1589-602.
  • Dong W, Chochua S, McGee L, Jackson D, Klugman KP, Vidal JE. Mutations within the rplD Gene of Linezolid-Nonsusceptible Streptococcus pneumoniae Strains Isolated in the United States.External Antimicrob Agents Chemother. 2014;58(4):2459-62.
  • Park IH, Geno KA, Sherwood LK, Nahm MH, Beall B. Population-based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes. PLoS One. 2014 May 15;9(5):e97825. doi: 10.1371/journal.pone.0097825. eCollection 2014.
  • Reynolds, C. A., J. A. Finkelstein, G. T. Ray, M. R. Moore, and S. S. Huang. “Attributable Healthcare Utilization and Cost of Pneumonia Due to Drug-Resistant Streptococcus Pneumonia: A Cost Analysis.” [In eng]. Antimicrob Resist Infect Control 3 (2014): 16.
  • Spicer JO, Thomas S, Holst A, Baughman W, Farley MM. Socioeconomic and Racial Disparities of Pediatric Invasive Pneumococcal Disease After the Introduction of the 7-valent Pneumococcal Conjugate Vaccine.External Pediatr Infect Dis J. 2014 Feb;33(2):158-64.
  • Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 2014; 63(27): 822-25.
  • Wortham JM, Zell E, Pondo T, Harrison L, Schaffner W, Lynfield R, Thomas A, Reingold A, Bennett N, Petit S, Aragon D, Bareta J, Juni B, Farley M, Beall B, Moore M. Racial Disparities in Invasive Streptococcus pneumoniae Infections, 1998-2009.External Clin Infect Dis. 2014; 58(9): 1250-7.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2013.
  • Centers for Disease Control and Prevention. Us of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6-18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep, 2013; 62(25):521-24.
  • Cho BH, Stoecker C, Link-Gelles R, Moore MR. Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions. Vaccine, 2013 Dec 5;31(50):6011-21. doi: 10.1016/j.vaccine.2013.10.024. Epub 2013 Oct 19.
  • Dallas SD, McGee L, Limbago B, Patel JB, McElmeel ML, Fulcher LC, Lonsway DR, Jorgensen JH. Development of doxycycline MIC and disk diffusion interpretive breakpoints and revision of tetracycline breakpoints for Streptococcus pneumoniae.External J Clin Microbiol. 2013 Jun;51(6):1798-802.
  • Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O’Brien KL, Moore MR; Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013;10(9):e1001517. doi: 10.1371/journal.pmed.1001517. Epub 2013 Sep 24.
  • Fleming-Dutra KE, Taylor T, Link-Gelles R, et al. Effect of the 2009 Influenza A(H1N1) Pandemic on Invasive Pneumococcal Pneumonia. J Infect Dis 2013. doi:10.1093/infdis/jit008
  • Link-Gelles R, Taylor T, Moore MR; for the Active Bacterial Core Surveillance Team. Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020.External Vaccine 2013 Apr 11. [Epub ahead of print]
  • Link-Gelles R, Thomas A, Lynfield R, Petit S, Schaffner W, Harrison L, Farley MM, Aragon D, Nicols M, Kirley PD, Zansky S, Jorgensen J, Juni BA, Jackson D, Moore MR, Lipsitch M. Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States.External J Infect Dis. 2013 Oct 15;208(8):1266-73. doi: 10.1093/infdis/jit315.
  • Payne AB, Link-Gelles R, Azonobi I, Hooper WC, Beall BW, Jorgensen JH, Juni B, Moore M; for the Active Bacterial Core Surveillance Team. Invasive Pneumococcal Disease among Children with and without Sickle Cell Disease in the United States, 1998-2009.External Pediatr Infect Dis J 2013 Jun 27. [Epub ahead of print]
  • Stoecker C, Hampton LM, Link-Gelles R, Messonnier ML, Zhou F, Moore MR. Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccine. Pediatrics. 2013 Aug;132(2):e324-32. doi: 10.1542/peds.2012-3350. Epub 2013 Jul 1.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2012.
  • Centers for Disease Control and Prevention. Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older. Morb Mortal Wkly Rep, 2012; 61(21): 394-95.
  • Cohen AL, Taylor T, Farley MM, Schaffner W, Lesher LJ, Gershman KA, Bennett NM, Reingold A, Thomas A, Baumbach J, Harrison LH, Petit S, Beall B, Zell E, Moore M. As assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States. PLoS One. 2012:7(8):e41785. Epub 2012 Aug 1.
  • De Serres G, Pilishvili T, Link-Gelles R, Reingold A, Gershman K, Petit S, Farley MM, Harrison LH, Lynfield R, Bennett NM, Baumbach J, Thomas A, Schaffner W, Beall B, Whitney C, Moore M. Use of surveillance date to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9-year period. Vaccine. 2012 Jun 8; 30(27):4067-72.
  • Golubchik T, Brueggemann AB, Street T, Gertz RE Jr, Spencer CC, Ho T, Giannoulatou E, Link-Gelles R, Harding RM, Beall B, Peto TE, Moore MR, Donnelly P, Crook DW, Bowden R. Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nature genetics 2012;44:352-5.
  • Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, Baumbach J, Beall B, Jorgensen J, Glennen A, Zell ER, Moore M. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis. February 2012;205(3):401-11.
  • Hampton LM, Zell ER, Schrag S, Cohen AL. Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness. Bull World Health Organ. 2012 Aug 1; 90(8):568-77.
  • Muhammad RD, Oza-Frank R, Zell E, Link-Gelles R, Narayan KM, Schaffner W, Thomas A, Lexau C, Bennett NM, Farley MM, Reingold A, Hadler J, Beall B, Klugman KP, Moore MR. Epidemiology of Invasive Pneumococcal Disease among High-Risk Adults since Introduction of Pneumococcal Conjugate Vaccine for Children. Clin Infect Dis. 2012 Nov 15 [Epub ahead of print].
  • Nelson GE, Gershman KA, Swerdlow DL, Beall BW, Moore MR. Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA. Emerg Infect Dis. 2012 Feb; 18(2):208-16.
  • Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S, Moore MR, Huang SS. Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis 2012;205:1589-92.
 Top of Page
  • Silk BJ, Date KA, Jackson KA, Pouillot R, Holt KG, Graves LM, Kanyin LO, Hurd S, Meyer R, Marcus R, Shiferaw B, Norton DM, Medus C, Zansky SM, Cronquist AB, Henao OL, Jones TF, Vugia DJ, Farley MM, Mahon BE. Invasive Listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009: further targeted prevention needed for higher-risk groups. Clin Infect Dis. 2012 Jun 01;54(5):S296-S404.
  • Pouillot R, Hoelzer K, Jackson KA, Henao OL, Silk BJ. Relative risk of Listeriosis in Foodborne Diseases Active Surveillance Network (FoodNet) sites according to age, pregnancy, and ethnicity. Clin Infect Dis. 2012 Jun 01;54(5):S405-S410.
  • Kendall ME, Crim S, Fullerton K, Han PV, Conquist AB, Shiferaw B, Ingram AL, Rounds J, Mintz ED, Mahon BE. Travel-associated enteric infections diagnosed after return to the United States, Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009. Clin Infect Dis. 2012 Jun 1;54(5):S480-S487.
  • Shiferaw B, Solghan S, Palmer A, Joyce K, Barzilay EJ, Krueger A, Cieslak P. Antimicrobial susceptibility patterns of Shigella isolates in Foodborne Diseases Active Surveillance Network (FoodNet) sites, 2000-2012. Clin Infect Dis. 2012 Jun 1;54(5):S458-S463.
  • Limbago B, Thompson AD, Greene SA, MacCannell D, MacGowan CE, Jolbitado B, Hardin HD, Estes SR, Weese JS, Songer JG, Gould LH. Development of a consensus method for culture of Clostridium difficile from meat and its use in a survey of US retail meats. Food Microbiol. 2012 Dec;32(2):448-51.
  • Batz MB, Hoffmann S, Morris JG Jr. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot. 2012 Jul; 75(7): 1278-91.
  • Cummings KJ, Warnick LD, Grohn YT, Hoelzer K, Root TP, Siler JD, McGuire SM, Wright EM, Zansky SM, Wiedmann M. Clinical features of human salmonellosis caused by bovine-associated subtypes in New York. Foodborne Pathog Dis. 2012 Sep; 9(9):796-802.
  • Mody Rk, Luna-Gierke RE, Jones TF, Comstock N, Hurd S, Scheftel J, Lathrop S, Smith G, Palmer A, Strockbine N, Talkington D, Mahon BE, Hoekstra RM. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying Shiga toxin-producing Escherichia coli. Arch Pediatr Adolesc Med. 2012 Oct;166(10):902-9.
  • Murphree R, Garman K, Phan Q, Everstine K, Gould LH, Jones TF. Characteristics of foodborne disease outbreak investigations conducted by Foodborne Diseases Active Surveillance Network (FoodNet) sites, 2003-2008. Clin Infect Dis. 2012 Jun; 54(5):S498-S4503.
  • Chai SJ, White PL, Lathrop SL, Sloghan SM, Medus C, McGlinchey BM, Tobin-D’Angelo M, Marcus R, Mahon BE. Salmonella enterica serotype Enteritidis: increasing incidence of domestically acquired infections. Clin Infect Dis. 2012 Jun;54(5):S488-S497.
  • Ailes E, Scallan E, Berkelman RL, Kleinbaum DG, Tauxe RV, Moe CL. Do differences in risk factors, medical care seeking, or medical practices explain the geographic variation in campylobacteriosis in Foodborne Diseases Active Surveillance Network (FoodNet) sites? Clin Infect Dis. 2012 Jun; 54(5):S464-S471.
  • Shiferaw B, Verril L, Booth H, Zansky SM, Norton DM, Crim S, Henao OL. Sex-based differences in food consumption: Foodborne Diseases Active Surveillance Network (FoodNet) population survey, 2006-2007. Clin Infect Dis. 2012 Jun; 54(5): S453-S457.
  • Clogher P, Hurd S, Hoefer D, Hadler JL, Pasutti L, Cosgrove S, Segler S, Tobin-D’Angelo M, Nichols. Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet). Clin Infect Dis. 2012 Jun; 54(5):S446-452.
  • Hurd S, Patrick M, Hatch J, Clogher P, Wymore K, Cronquist AB, Segler S, Robinson T, Sanna S, Smith G, Fitzgerald C. Clinical laboratory practices for the isolation and identification of Campylobacter in Foodborne Diseases Active Surveillance Network (FoodNet) sites: baseline information for understanding changes in surveillance data. Clin Infect Dis. 2012 Jun;54(5):S440-S445.
  • Ong KL, Apostal M, Comstock N, Hurd S, Webb TH, Mickelson S, Scheftel J, Smith G, Shiferaw B, Boothe E, Gould LH. Strategies for surveillance of pediatric hemolytic uremic syndrome: Foodborne Diseases Active Surveillance Network (FoodNet), 2000-2007. Clin Infect Dis. 2012 Jun; 54(5):S424-431.
  • Manikonda K, Palmer A, Wymore K, McMillian M, Nicholson C, Hurd S, Hoefer D, Tobin-D’Angelo M, Cosgrove S, Lyons C, Lathrop S, Hedican E, Patrick M. Validating deaths reported in the Foodborne Diseases Active Surveillance Network (FoodNet): are all deaths being captured? Clin Infect Dis. 2012 Jun; 54(5):S421-423.
  • Henao OL, Crim SM, Hoekstra RM. Calculating a measure of overall change in the incidence of selected laboratory-confirmed infections with pathogens transmitted commonly through good in the Foodborne Diseases Active Surveillance Network (FoodNet), 1996-2010. Clin Infect Dis. 2012 Jun; 54(5):S418-S420.
  • Hall RL, Jones JL, Hurd S, Smith G, Mahon BE, Herwaldt BL. Population-based active surveillance for Cyclospora infection – United States, Foodborne Diseases Active Surveillance Network (FoodNet), 1997-2009. Clin Infect Dis. 2012 Jun;54(5):S411-417.
  • Silk BJ, Date KA, Jackson KA, Pouillot R, Holt KG, Graves LM, Ong KL, Hurd S, Meyer R, Marcus R, Shiferaw B, Norton DM, Medus C, Zanksy SM, Cronquist AB, Henao OL, Jones TF, Vugia DJ, Farley MM, Mahon BE.
  • Newton A, Kendall M, Vugia DJ, Henao OL, Mahon BE. Increasing rates of vibriosis in the United States, 1996-2010: review of surveillance data from 2 systems. Clin Infect Dis. 2012 Jun;54(5):S391-395.
  • Ong KL, Gould LH, Chen DL, Jones TF, Scheftel J, Webb TH, Mody RK, Mahon BE. Changing epidemiology of Yersinia enterocolitica infections: markedly decreased rates in young black children, Foodborne Diseases Active Surveillance Network (FoodNet), 1996-2009. Clin Infect Dis. 2012 Jun;54(5):S385-S390.
  • Scallan E, Mahon BE. Foodborne Diseases Active Surveillance Network (FoodNet) in 2012: a foundation for food safety in the United States. Clin Infect Dis. 2012 Jun;54(5):S381-384.
  • Ebel ED, Williams MS, Schlosser WD. Parametric distributions of underdiagnosed parameters used to estimate annual burden of illness for five foodborne pathogens. J Food Prot. 2012 Apr;75(4):775-8.
  • Taylor EV, Holt KG, Mahon BE, Ayers T, Norton D, Gould LH. Ground beef consumption patterns in the United States, FoodNet, 2006-2007. J Food Prot. 2012 Feb;75(2):341.6.
  • Buzby JC, Gould LH, Kendall ME, Jones TF, Robinson T, Blayney DP. Characteristics of consumers of unpasteurized milk in the United States. J Consum Aff. 2013 Jan; 47(1):153-66.
  • Centers for Disease Control and Prevention (CDC). Incidence and trends of infection with pathogens transmitted commonly through food – Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 1996-2012. MMWR Morb Mortal Wkly Rep. 2013 Apr; 62(15):283-7.
  • Centers for Disease Control and Prevention (CDC). Vital signs: Listeria illnesses, deaths, and outbreaks –United States, 2009-2011. MMWR Morb Mortal Wkly Rep. 2013 Jun; 62(22):448-52.
  • Cheng LH, Crim SM, Cole CR, Shane AL, Henao OL, Mahon BE. Epidemiology of infant salmonellosis in the United States, 1996-2008: a Foodborne Diseases Active Surveillance Network study. J Ped Infect Dis. 2013 Apr; 2(3):232-9.
  • Cole D, Griffin PM, Fullerton KE, Ayers T, Smith K, Ingram LA Kissler B, Hoekstra M. Attributing sporadic and outbreak-associated infections to sources: blending epidemiological data. Epidemiol Infect. 2013 Apr; 142(2):1-8.
  • Gould LH, Mody RK, Ong KL, Clogher P, Cronquist AB, Garman KN, et al. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with coli O157 infections. Foodborne Pathog Dis. 2013 May; 10(5):453-60.
  • Gould LH, Rosenblum I, Nicholas D, Phan Q, Jones TF. Contributing factors in restaurant-associated foodborne disease outbreaks, FoodNet sites, 2006 and 2007. J Food Prot. 2013 Nov; 76(11):1824-8.
  • Marks HM, Tohamy SM, Tsui F. Modeling uncertainty of estimated illnesses attributed to non-O157:H7 Shiga toxin-producing Escherichia coli and its impact on illness cost. J Food Prot. 2013 Jun; 76(6):945-52.
  • Saupe AA, Kaehler D, Cebelinski EA, Nefzger B, Hall AJ, Smith KE. Norovirus surveillance among callers to foodborne illness complaint hotline, Minnesota, USA, 2011-2013. Emerg Infect Dis. 2013 Aug; 19(8):1293-6.
  • Scallan E, Mahon BE, Hoekstra RM, Griffin PM. Estimates of illnesses, hospitalizations and deaths caused by major bacterial enteric pathogens in young children in the United States. Pediatr Infect Dis J. 2013 Mar; 32(3):217-21.
  • Zappe Pasturel B, Cruz-Cano R, Rosenberg Goldstein RE, Palmer A, Blythe D, Ryan P, et al. Impact of rurality, broiler operations, and community socioeconomic factors on the risk of campylobacteriosis in Maryland. Am J Public Health. 2013 Dec; 103(12):2267-75.
  • Slayton RB, Turabelidze G, Bennett SD, Schwensohn CA, Yaffee AQ, Khan F, Butler C, Trees E, Ayers TL, Davis ML, Laufer AS, Gladbach S, Williams I, Gieraltowski LB. Outbreak of Shiga toxin-producing Escherichia coli (STEC) O157:H7 associated with romaine lettuce consumption, 2011. PLoS One. 2013;8(2):e55300.
  • Crim SM, Iwamoto M, Huang JY, Griffin PM, Gilliss D, Cronquist AB, et al. Incidence and trends of infection with pathogens transmitted commonly through food – Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006–2013. MMWR Morb Mortal Wkly Rep. 2014 Apr;63(15):328–32.
  • Danila RN, Eikmeier DL, Robinson TJ, La Pointe A, DeVries AS. Two concurrent enteric disease outbreaks among men who have sex with men, Minneapolis-St Paul area. Clin Infect Dis. 2014 Oct;59(7):987–9.
  • Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA. CDC national health report: leading causes of morbidity and mortality and associated behavioral risk and protective factors—United States, 2005–2013. MMWR Surveill Summ. 2014 Oct;63 Suppl 4:3–27.
  • Krueger AL, Greene SA, Barzilay EJ, Henao O, Vugia D, Hanna S, et al. Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal Salmonella infections compared with pansusceptible infections in FoodNet sites, 2006–2008. Foodborne Pathog Dis. 2014 May;11(5):335–41.
  • Luna-Gierke RE, Wymore K, Sadlowski J, Clogher P, Gierke RW, Tobin-D’Angelo M, et al. Multiple-aetiology enteric infections involving non-O157 Shiga toxin-producing Escherichia coli—FoodNet, 2001–2010. Zoonoses Public Health. 2014 Nov;61(7):492–8.
  • O’Donnell AT, Vieira AR, Huang JY, Whichard J, Cole D, Karp BE. Quinolone-resistant Salmonella enterica serotype Enteritidis infections associated with international travel. Clin Infect Dis. 2014 Nov;59(9):e139–41.
  • Patrick ME, Mahon BE, Greene SA, Rounds J, Cronquist A, Wymore K, et al. Incidence of Cronobacter infections, United States, 2003–2009. Emerg Infect Dis. 2014 Sep;20(9):1536–39.
  • Robinson TJ, Scheftel JM, Smith KE. Raw milk consumption among patients with non-outbreak-related enteric infections, Minnesota, USA, 2001–2010. Emerg Infect Dis. 2014 Jan;20(1):38–44.
  • Ricotta EE, Palmer A, Wymore K, Clogher P, Oosmanally N, Robinson T, et al. Epidemiology and antimicrobial resistance of international travel-associated Campylobacter infections in the United States, 2005–2011. Am J Public Health. 2014 Jul;104(7):e108–114.
  • Whitten T, Bender JB, Smith K, Leano F, Scheftel J. Reptile-associated salmonellosis in Minnesota, 1996–2011. Zoonoses Public Health. 2014 Jun.
  • Lunca-Gierke RE, Griffin PM, Gould H, Herman K, Bopp CA, Strockbine N, and ModyRK. Outbreaks of non-O157 Shiga toxin-producing Escherichia coli infection: USA. Epidemiology and Infection. 2014; 142:2270-2280.
  • Fitzgerald C, Chao Tu Z, Patrick M, Wagenaar JA. Campylobacter fetus subsp. testudinum subsp. nov., isolated from humans and reptiles. International Journal of Systematic and Evolutionary Microbiology. 2014 Jun;64(9).
  • Green AL, Seys S, Douris A, Levine J, Robertson K. Factors associated with regulatory action involving investigation of illnesses associated with Shiga toxin-producing Escherichia coli in products regulated by the Food Safety and Inspection Service. Foodborne Pathog Dis. 2014 Jul;11(7):568-573.
  • Cole D, Griffin PM, Fullerton KE, Ayers T, Smith K, Ingram LA, Kissler B, Hoekstra RM. Attributing sporadic and outbreak-associated infections to sources: blending epidemiological data. Epidemiol Infect. 2014 Feb;142(2):295-302.
  • Mody RK, Gu W, Griffin PM, Jones TF, Rounds J, Shiferaw B, Tobin-D’Angelo M, Smith G, Spina N, Hurd S, Lathrop S, Palmer A, Boothe E, Luna-Gierke RE, Hoekstra RM. Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death. J Pediatr. 2015 Apr;166(4):1022-9. doi: 10.1016/j.jpeds.2014.12.064. Epub 2015 Feb 4.
  • Iwamoto M, Huang JY, Cronquist AB, Medus C, Hurd S, Zansky S, Dunn J, Woron AM, Oosmanally N, Griffin PM, Besser J, Henao OL; Centers for Disease Control and Prevention (CDC). Bacterial enteric infections detected by culture-independent diagnostic tests–FoodNetExternal, United States, 2012-2014. MMWR Morb Mortal Wkly Rep. 2015 Mar 13;64(9):252-7.
  • Crim SM, Griffin PM, Tauxe R, Marder EP, Gilliss D, Cronquist AB, Cartter M, Tobin-D’Angelo M, Blythe D, Smith K, Lathrop S, Zansky S, Cieslak PR, Dunn J, Holt KG, Wolpert B, Henao OL; Centers for Disease Control and Prevention (CDC). Preliminary incidence and trends of infection with pathogens transmitted commonly through food – Foodborne Diseases Active Surveillance NetworkExternal, 10 U.S. sites, 2006-2014. MMWR Morb Mortal Wkly Rep. 2015 May 15;64(18):495-9.
  • Jiang C, Shaw KS, Upperman CR, Blythe D, Mitchell C, Murtugudde R, Sapkota AR, Sapkota A. Climate change, extreme events and increased risk of salmonellosis in Maryland, USA: Evidence for coastal vulnerabilityExternal. Environ Int. 2015 Oct;83:58-62.
  • Scallan E, Crim SM, Runkle A, Henao OL, Mahon BE, Hoekstra RM, Griffin PM. Bacterial Enteric Infections Among Older Adults in the United States: Foodborne Diseases Active Surveillance Network, 1996-2012External. Foodborne Pathog Dis. 2015 Jun;12(6):492-9.
  • Hadler JL, Danila RN, Cieslak PR, Meek JI, Schaffner W, Smith KE, Cartter ML, Harrison LH, Vugia DJ, Lynfield R. Emerging Infections Program-State Health Department Perspective.External Emerg Infect Dis. 2015 Sep;21(9):1510-5.
  • Henao OL, Jones TF, Vugia DJ, Griffin PM; Foodborne Diseases Active Surveillance Network (FoodNet) Workgroup. Foodborne Diseases Active Surveillance Network-2 Decades of AchievementsExternal, 1996-2015. Emerg Infect Dis. 2015 Sep;21(9):1529-36.
  • Langley G, Besser J, Iwamoto M, Lessa FC, Cronquist A, Skoff TH, Chaves S, Boxrud D, Pinner RW, Harrison LH. Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program SurveillanceExternal. Emerg Infect Dis. 2015 Sep;21(9):1582-8.
  • Vugia DJ, Meek JI, Danila RN, Jones TF, Schaffner W, Baumbach J, Lathrop S, Farley MM, Tobin-D’Angelo M, Miller L, Harrison LH, Bennett NM, Cieslak PR, Cartter ML, Reingold AL. Training in Infectious Disease Epidemiology through the Emerging Infections Program SitesExternal. Emerg Infect Dis. 2015 Sep;21(9):1516-9.
  • Whitney BM, Mainero C, Humes E, Hurd S, Niccolai L, Hadler JL. Socioeconomic Status and Foodborne Pathogens in Connecticut, USA, 2000-2011External. Emerg Infect Dis. 2015 Sep;21(9):1617-24.
  • Boore AL, Hoekstra RM, Iwamoto M, Fields PI, Bishop RD, Swerdlow DL (2015) Salmonella enterica infections in the United States and assessment of coefficients of variation: a novel approach to Identify epidemiologic characteristics of individual serotypes, 1996–2011. PLoS ONE. Dec 2015;10(12): e0145416.
  • Wright AP, Richardson L, Mahon BE, Rothenberg R, Cole DJ. The rise and decline in Salmonella enterica serovar Enteritidis outbreaks attributed to egg-containing foods in the United States, 1973-2009. Epidemiol Infect. Mar 2016; 144(4):810-819.
  • Taylor A, Lappi V, Wolfgang W, Lapierre P, Palumbo M, Medus C, Boxrud D. Characterization of foodborne outbreaks of Salmonella enterica serovar Enteritidis with whole genome sequencing SNP-based analysis for surveillance and outbreak detection. J Clin Microbiology. 2015 Oct; 53 (10): 3334-40.
  • Heiman KE, Garalade VB, Gronostaj M, Jackson KA, Beam S, Joseph L, Saupe A, Ricotta E, Waechter H, Wellman A, Adams-Cameron M, Ray G, Fields A, Chen Y, Datta A, Burall L, Sabol A, Kucerova Z, Trees E, Metz M, Leblanc P, Lance S, Griffin PM, Tauxe RV, Silk BJ. Multistate outbreak of listeriosis caused by imported cheese and evidence of cross-contamination of other cheeses, USA, 2012. Epidemiol Infect. 2015 Jun; 30:1-11.
  • Lynfield R, Schafner W. Emerging Infections Program – 20 years of achievements and future prospects. Emerg Infect Dis. 2015 Sep 21; 9: 1497-8.
  • Jackson BR, Salter M, Tarr C, Conrad A, Harvey E, Steinbock L, Saupe A, Sorenson A, Katz L, Stroika S, Jackson KA, Carleton H, Kucerova Z, Melka D, Strain E, Parish M, Mody RK. Notes from the field: Listeriosis associated with stone fruit – United States, 2014. 2015; 64:282-3.
  • Bowen A, Eikmeier D, Talley P, Siston A, Smith S, Hurd J, Smith K, Leano F, Bicknese A, Corbin  Norton J, Campbell D. Notes from the Field: Outbreaks of Shigella sonnei infection with decreased susceptibility to azithromycin among men who have sex with men — Chicago and Metropolitan Minneapolis-St. Paul, 2014. 2015; 64(21); 597-8.
  • Whitten T, Bender JB, Smith K, Leano F, Scheftel J. Reptile-associated salmonellosis in Minnesota, 1996-2011. Zoonoses Public Health. 2015 May 62; 3: 199-208.
  • Rosenberg Goldstein RE, Cruz-Cano R, Jiang C, Palmer A, Blythe D, Ryan P, Hogan B, White B, Dunn JR, Libby T, Tobin-D’Angelo M, Huang JY, McGuire S, Scherzinger K, Ting Le, M, Sapkota AR. Association between community socioeconomic factors, animal feeding operations, and campylobacteriosis incidence rates: Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2010. BMC Infectious Diseases. 2016 22 Jul;16:354.
  • Shaw KS, Cruz-Cano R, Jiang C, Malayil L, Blythe D, Ryan P, Sapkota AR. Presence of animal feeding operations and community socioeconomic factors impact salmonellosis incidence rates: An ecological analysis using data from the Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2010. Environmental Research. 2016 9 Jun; 150:166-172.
  • Wright AP, Richardson L, Mahon BE, Rothenbeg R, Cole DJ. The rise and decline in Salmonella enterica serovar Enteritidis outbreaks attributed to egg-containing foods in the United States, 1973–2009. Epidemiol Infect. 2016 Mar;144(4):810–9.
  • Date KA, Newton AE, Medalla F, Blackstock A, Richardston L, McCullough A, Mintz ED, Mahon BE. Changing patterns in enteric fever incidence and increasing antibiotic resistance of enteric fever isolates in the United States, 2008–2012. Clin Infect Dis. 2016 Aug 1.
  • Huang JY, Henao OL, Griffin PM, Vugia DJ, Cronquist AB, Hurd S, Tobin-D’Angelo M, Ryan P, Smith K, Lathrop S, Zansky S, Cieslak PR, Dunn J, Holt KG, Wolpert BJ, Patrick ME; Centers for Disease Control and Prevention (CDC). Infection with pathogens transmitted commonly through food and the effect of increasing use of culture-independent diagnostic tests on surveillance — Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2012–2015. MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14);368-371.
  • Boore AL, Hoekstra RM, Iwamoto M, Fields PI, Bishop RD, Swerdlow DL. Salmonella enterica infections in the United States and assessment of coefficients of variation: a novel approach to identify epidemiologic characteristics of individual serotypes, 1996–2011. PLoS One. 2015 Dec 23;10(12):e0145416.
  • Foodborne Diseases Active Surveillance Network (FoodNet): FoodNet Surveillance Report for 2014 (Final Report). Atlanta, Georgia: U.S. Department of Health and Human Services, CDC. 2016.
  • Ebel ED, Williams MS, Cole D, Travis CC, Klontz KC, Golden NJ, Hoekstra RM. Comparing characteristics of sporadic and outbreak-associated foodborne illnesses, United States, 2004-2011. Emerg Infect Dis. 2016 Jul; 22(7):1193-1200.
  • Gu W, Vieira AR, Hoekstra RM, Griffin PM, Cole D. Use of random forest to estimate population attributable fractions from a case-control study of Salmonella enterica serotype Enteritidis infections. Epidemiol Infect. 2015 Oct;143(13):2786–94.
  • Huang JY, Henao OL, Griffin PM, Vugia DJ, Cronquist AB, Hurd S, Tobin-D’Angelo M, Ryan P, Smith K, Lathrop S, Zansky S, Cieslak PR, Dunn J, Holt KG, Wolpert BJ, Patrick ME; Centers for Disease Control and Prevention (CDC). Infection with pathogens transmitted commonly through food and the effect of increasing use of culture-independent diagnostic tests on surveillance — Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2012–2015. MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14);368-371.
  • Jiang C, Shaw KS, Upperman CR, Blythe D, Mitchell C, Murtugudde R, Sapkota AR, Sapkota A. Climate change, extreme events and increased risk of salmonellosis in Maryland, USA: evidence for coastal vulnerability. Environment International. 2015 Oct; 83:58-62.
  • Rivas M, Chinen I, Guth BEC. Enterohemorrhagic (shiga toxin-producing) Escherichia coli. In: Torres AG, editor. Escherichia coli in the Americas. Switzerland: Springer International Publishing. 2016 Oct: 97-123.
  • Rosenberg Goldstein RE, Cruz-Cano R, Jiang C, Palmer A, Blythe D, Ryan P, Hogan B, White B, Dunn JR, Libby T, Tobin-D’Angelo M, Huang JY, McGuire S, Scherzinger K, Ting Lee ML, Sapkota AR. Association between community socioeconomic factors, animal feeding operations, and campylobacterosis incidence rates: Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2010. BMC Infectious Diseases. 2016 Jul;16:354.
  • Scallan E, Hoekstra RM, Mahon BE, Jones TF, Griffin PM. An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years. Epidemiol Infect. 2015 Oct;143(13):2795–804.
  • Jones TF, Sashti N, Ingram A, Phan Q, Booth H, Rounds J, Nicholson CS, Cosgrove S, Crocker K, Gould LH. Characteristics of clusters of Salmonella and Escherichia coli O157 detected by pulsed-field gel electrophoresis that predict identification of outbreaks. Foodborne Patog Dis. 2016 Dec;13(12):674-678.
  • Marder E, Geissler A. Incidence and trends of infection with pathogens transmitted commonly through food – Foodborne Diseases Active Surveillance Network, 2013-2016. MMWR Morb Mortal Wkly Rep. 2017 Apr 20.
 Top of Page
  • Oboho I, Reed C, Gargiullo P, Leon M, Aragon D, Meek J, Anderson E, Ryan P, Lynfield R, Morin C, Bargsten M, Zansky S, Fowler B, Thomas A, Lindegren ML, Schaffner W, Risk I, Finelli L, Chaves S. The benefit of early influenza antiviral treatment of pregnant women hospitalized with laboratory-confirmed influenza. Journal of Infectious Diseases. 2016 Feb 3. doi: 1093/infdis/jiw033.
  • Rolfes M, Yousey-Hindes K, Meek J, Fry A, Chaves S. Influenza Testing and Antiviral Prescriptions During Acute Respiratory Hospitalizations. Open Forum Infectious Disease. 2016 Feb 12; 3(1):ofv216. doi: 1093/ofid/ofv216 PubMed PMID: 26885545.
  • Hadler J, Yousey-Hindes K, Perezz A, Anderson E, Bargsten M, Bohm S, Hill M, Hogan H, Laidler M, Lindegren ML, Lung K, Mermel E, Miller L, Morin C, Parker E, Zansky S, Chaves S. Influenza-related hospitalizations and poverty levels –United States, 2010-2012. Morbidity and Mortality Weekly Report. 2016 Feb 12; 65(5):101-5. doi: 15585/mmwr.mm6505a1 PubMed PMID: 26866729.
  • Havers F, Sokolow L, Shay D, Farley M, Monroe M, Meek J, Daily Kirley P, Bennett N, Morin C, Aragon D, Thomas A, Schaffner W, Zansky S, Baumbach J, Ferdinands J, Fry A. Case-control study of vaccine effectiveness in preventing hospitalizations in older adults, United Sates, 2010-11. Clinical Infectious Diseases. 2016 Aug 2; 63 (4) doi:10.1093/cid/ciw512
  • Appiah G, Chaves S, Daily Kirley P, Miller L, Meek J, Anderson E, Oni O, Eckel S, Lynfield R, Bargsten M, Zansky S, Bennett N, Lung K, McDonald-Hamm C, Thomas A, Brady D, Lindegren M, Schaffner W, Hill M, Garg S, Fry A, Campbell A. Increased Antiviral Treatment among Hospitalized Children and Adults with Laboratory-Confirmed Influenza, 2010-2015. Clinical Infectious Diseases. 2017 Dec 23; 64 (3):364-367. doi:10.1093/cid/ciw745.
  • Chaves S, Lynfield R, Lindegren ML, Bresee J, Finelli L. The US Influenza Hospitalization Surveillance Network. Emerging Infectious Diseases. 2015 Sep;21(9):1543-50. doi: 10.3201/eid2109.141912.PubMed PMID: 26291121.
  • Chaves S, Pérez A, Miller L, Bennett N, Bandyopadhyay A, Farley M, Fowler B, Hancock E, Daily Kirley P, Lynfield R, Ryan P, Morin C, Schaffner W, Sharangpani R, Lindegren M, Tengelsen L, Thomas A, Hill M, Bradley K, Oni O, Meek J, Zanksy S, Widdowson MA, Finelli L. Impact of prompt influenza antiviral on extended care needs after influenza hospitalization among community-dwelling older adults. Clinical Infect Dis. 2015 Sep 2. pii:civ733 [Epub ahead of print] PubMed PMID: 26334053.
  • Matthew R. Laidler, Ann Thomas, Joan Baumbach, Pam Daily Kirley, James Meek, Deborah Aragon, Craig Morin, Patricia Ryan, William Schaffner, Shelley M. Zansky, and Sandra S. Chaves. Statin treatment and mortality: propensity score-matched analyses of 2007–2008 and 2009–2010 laboratory-confirmed influenza hospitalizations. Open Forum Infect Dis 2015: ofv028v1-ofv028.
  • Arriola CS, Anderson EJ, Baumbach J, Bennett N, Bohm S, Hill M, Lindegren ML, Lung K, Meek J, Mermel E, Miller L, Monroe ML, Morin C, Oni O, Reingold A, Schaffner W, Thomas A, Zansky SM, Finelli L, Chaves SS. Does influenza vaccination modify influenza disease severity? Data on older adults hospitalized with influenza during the 2012-13 season in the United States. J Infect Dis. 2015Mar 27. pii: jiv200. [Epub ahead of print] PubMed PMID: 25821227.
  • Reed C, Chaves SS, Daily Kirley P, Emerson R, Aragon D, Hancock EB, Butler L, Baumbach J, Hollick G, Bennett NM, Laidler MR, Thomas A, Meltzer MI, Finelli L. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One. 2015 Mar 4;10(3):e0118369. doi: 10.1371/journal.pone.0118369. eCollection 2015.
  • Garg S, Jain S, Dawood FS, Jhung M, Pérez A, D’Mello T, Reingold A, Gershman K, Meek J, Arnold KE, Farley MM, Ryan P, Lynfield R, Morin C, Baumbach J, Hancock EB, Zansky S, Bennett N, Thomas A, Schaffner W, Finelli L. Pneumonia among Adults Hospitalized with Laboratory-Confirmed Seasonal Influenza Virus Infection – United States, 2005-2008. BMC Infect Dis. 2015 Aug 26; 15(369). doi:10.1186/s12879-015-1004-y PubMed PMID: 26307108.
  • Reed C, Kim IK, Singleton JA, Chaves SS, Flannery B, Finelli L, Fry A, Burns E, Gargiullo P, Jernigan D, Cox N, Bresee J; Centers for Disease Control and Prevention (CDC). Estimated influenza illnesses and hospitalizations averted by vaccination–United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1151-4.
  • Fry AM, Kim IK, Reed C, Thompson M, Chaves SS, Finelli L, Bresee J. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Clin Infect Dis. 2014 Aug 1;59(3):406-9. doi: 10.1093/cid/ciu328. Epub 2014 May 6 PubMed PMID: 24803379.
  • Reed C, Chaves SS, Pérez A, D’Mello T, Daily Kirley P, Aragon D, Meek JI, Farley MM, Ryan P, Lynfield R, Morin CA, Hancock EB, Bennett NM, Zansky SM, Thomas A, Lindegren ML, Schaffner W, Finelli L. Complications Among AdultsHospitalized With Influenza: A Comparison of Seasonal Influenza and the 2009 H1N1 Pandemic. Clin Infect Dis. 2014 Jul 15;59(2):166-74. doi: 10.1093/cid/ciu285. Epub 2014 Apr 29. PubMed PMID: 24785230.
  • Su S, Chaves SS, Pérez A, D’Mello T, Kirley PD, Yousey-Hindes K, Farley MM, Harris M, Sharangpani R, Lynfield R, Morin C, Hancock EB, Zansky S, Hollick GE, Fowler B, McDonald-Hamm C, Thomas A, Horan V, Lindegren ML, Schaffner W, Price A, Bandyopadhyay A, Fry AM. Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza a and B virus infection. Clin Infect Dis. 2014 Jul 15;59(2):252-5. doi: 10.1093/cid/ciu269. Epub 2014 Apr 18. PubMed PMID: 24748521.
  • Dharan NJ, Sokolow LZ, Cheng PY, Gargiullo P, Gershman K, Lynfield R, Morin C, Thomas A, Meek J, Farley MM, Arnold KE, Reingold A, Craig AS, Schaffner W, Bennett NM, Zansky S, Baumbach J, Lathrop S, Kamimoto L, Shay DK. Child, Household, and Caregiver Characteristics Associated with Hospitalization for Influenza among Children 6-59 Months of Age: An Emerging Infections Program Study. Pediatr Infect Dis J. 33(6) June 2014.
  • Chaves SS, Pérez A, Farley MM, Miller L, Schaffner W, Lindegren ML, Sharangpani R, Meek J, Yousey-Hindes K, Thomas A, Boulton R, Baumbach J, Hancock EB, Bandyopadhyay AS, Lynfield R, Morin C, Zansky SM, Reingold A, Bennett NM, Ryan P, Fowler B, Fry A, Finelli L; for the Influenza Hospitalization Surveillance Network. The Burden of Influenza Hospitalizations in Infants from 2003- 2012, United States. Pediatr Infect Dis J. 2014 Feb 26. [Epub ahead of print] PubMed PMID: 24577042.
  • Dawood FS, Chaves SS, Pérez A, Reingold A, Meek J, Farley MM, Ryan P, Lynfield R, Morin C, Baumbach J, Bennett NM, Zansky S, Thomas A, Lindegren ML, Schaffner W, Finelli L; for the Emerging Infections Program Network. Complications and associated bacterial co-infections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010.External J Infect Dis. 2014 Mar;209(5):686-94. doi:10.1093/infdis/jit473. Epub 2013 Aug 28. PubMed PMID: 23986545.
  • Greenbaum A, Chaves SS, Pérez A, Aragon D, Bandyopadhyay A, Bennett N, Fowler B, Hancock E, Lynfield R, McDonald-Hamm C, Reingold A, Ryan P, Schaffner W, Sharangpani R, Spencer M, Thomas A, Yousey-Hindes K, Zansky S, Finelli L. Heavy alcohol use as a risk factor for severe outcomes among adults hospitalized with laboratory-confirmed influenza, 2005-2012. Infection. 2014 Feb;42(1):165-70. doi: 10.1007/s15010-013-0534-8. Epub 2013 Nov 16. PubMed PMID: 24243481.
  • Jhung MA, D’Mello T, Pérez A, Aragon D, Bennett NM, Cooper T, Farley MM, Fowler B, Grube SM, Hancock EB, Lynfield R, Morin C, Reingold A, Ryan P, Schaffner W, Sharangpani R, Tengelsen L, Thomas A, Thurston D, Yousey-Hindes K, Zansky S, Finelli L, Chaves SS. Hospital-onset influenza hospitalizations-United States, 2010-2011. Am J Infect Control. 2014 Jan;42(1):7-11. doi: 10.1016/j.ajic.2013.06.018. Epub 2013 Oct 30. PubMed PMID: 24183534.
  • Tam K, Yousey-Hindes K, Hadler JL. Influenza-related hospitalization of adults associated with low census tract socioeconomic status and female sex in New Haven County, Connecticut, 2007-2011. Influenza Other Respir Viruses. 2014 Jan 2. doi: 10.1111/irv.12231. [Epub ahead of print] PubMed PMID: 24382111.
  • Centers for Disease Control and Prevention (CDC). Estimated Influenza Illnesses and Hospitalizations Averted by Influenza Vaccination – United States, 2012-13 Influenza Season. MMWR 2013;62(49):[997-1000].
  • Thompson M, Sokolow LZ, Almendares O, Openo K, Farley MM, Meek J, Ray J, Kirley PD, Reingold A, Aragon D, Hancock E, Baumbach J, Schaffner W, Lynfield R, Ryan P, Monroe M, Cheng PY, Fry A, Shay DK. Effectiveness of non-adjuvanted monovalent A(H1N1)pdm09 vaccines for preventing RT-PCR-confirmed pandemic influenza hospitalizations: Case-control study of children and adults at ten U.S. Influenza Surveillance Network sites.External Clin Infect Dis. 2013 Dec;57(11):1587-92. doi: 10.1093/cid/cit551. Epub 2013 Aug 15. PubMed PMID: 23956169.
  • Chaves SS, Aragon D, Bennett N, Cooper T, D’Mello T, Farley M, Fowler B, Hancock E, Kirley PD, Lynfield R, Ryan P, Schaffner W, Sharangpani R, Tengelsen L, Thomas A, Thurston D, Williams J, Yousey-Hindes K, Zansky S, Finelli L. Patients hospitalized with laboratory-confirmed influenza during the 2010-2011influenza season: exploring disease severity by virus type and subtype. J Infect Dis. 2013 Oct 15;208(8):1305-14. doi: 10.1093/infdis/jit316.
  • Kostova D, Reed C, Finelli L, Cheng PY, Gargiullo PM, Shay DK, Singleton JA, Meltzer MI, Lu PJ, Bresee JS. Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PLoS One. 2013 Jun 19;8(6):e66312. Print 2013. PubMed PMID: 23840439; PubMed Central PMCID: PMC3686813.
  • Fleming-Dutra KE, Taylor T, Link-Gelles R, Garg S, Jhung MA, Finelli L, Jain S, Shay D, Chaves SS, Baumbach J, Hancock EB, Beall B, Bennett N, Zansky S, Petit S, Yousey-Hindes K, Farley MM, Gershman K, Harrison LH, Ryan P, Lexau C, Lynfield R, Reingold A, Schaffner W, Thomas A, Moore MR. Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia.External J Infect Dis. 2013 Apr;207(7):1135-43. doi: 10.1093/infdis/jit008. Epub 2013 Jan 9. PubMed PMID: 23303809.
  • Cox CM, D’Mello TA, Pérez A, Reingold A, Gershman, K, Yousey-Hindes K, Arnold K, Farley MM, Ryan P, Lynfield R, Baumbach J, Zansky S, Bennett N, Thomas A, Schaffner W, and Finelli L for the Emerging Infections Program (EIP) Network. Increase in laboratory-confirmed, influenza hospitalization rates among children and adults during the 2009 H1N1 pandemic.  Journal of Infectious Diseases 2012; 206(9): 1350-1358.
  • Garg, S, Chaves S, Pérez A, D’Mello T, Reingold A, Gershman K, Meek J, Yousey-Hindes K, Arnold K, Farley M, Tengelsen L, Ryan P, Sharangpani R, Lynfield R, Morin C, Baumbach J, Hancock E, Zansky S, Bennett N, Fowler B, Bradley K, Thomas A, Cooper T, Schaffner W, Boulton R, Finelli L, Fry A. Antiviral Treatment among Children and Adults Hospitalized with Laboratory- Confirmed Influenza after the 2009 Pandemic, 2010- 2011. Clinical Infectious Diseases 2012; doi: 10.1093/cid/cis442.
  • Luckhaupt S, Sweeney MH, Funk R, Calvert G, Nowell M, D’Mello TA, Reingold A, Meek J, Yousey-Hindes K, Arnold KE, Ryan P, Lynfield R, Morin C, Baumbach J, Zansky S, Bennett NM, Thomas A, Schaffner W, Jones T. Influenza hospitalizations among workers by industry during the 2009-2010 influenza season.  Emerging Infectious Diseases 2012; 18(4): 556-62.
  • Vandermeer M, Thomas A, Kamimoto L, Reingold A, Gershman K, Meek J, Farley M, Ryan P, Lynfield R, Baumbach J, Schaffner W, Bennett N, Zansky, S. Association between Statins and Mortality among Patients Hospitalized with Lab-confirmed Influenza Infections: a Multi-state Study. Journal of Infectious Diseases 2012; 205(1): 13-19.
 Top of Page

Clostridium difficile Infection (CDI)

  • AS Chitnis, SM Holzbauer, RM Belflower, LG Winston, WM Bamberg, C Lyons, MM Farley, GK Dumyati, LE Wilson, ZG Beldavs, JR Dunn, LH Gould, DR MacCannell, DN Gerding, LC McDonald, FC Lessa. Epidemiology of community-associated Clostridium difficile infection, 2009–2011. JAMA Intern Med 2013;173:1359-67.
  • Centers for Disease Control and Prevention (CDC). Vital Signs: Preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012;61(9):157-62.
  • Pawar D, Tsay R, Nelson DS, Elumalai MK, Lessa FC, Clifford McDonald L, Dumyati G. Burden of Clostridium difficile infection in long-term care facilities in Monroe County, New York. Infect Control Hosp Epidemiol. 2012;33(11):1107-12.
  • Gould CV, Edwards JR, Cohen J, Bamberg WM, Clark LA, Farley MM, Johnston H, Nadle J, Winston L, Gerding DN, McDonald LC, Lessa FC. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 2013;57(9):1304-7.
  • Cohen J, Limbago L, Dumyati G, Holzbauer S, Johnston H, Perlmutter R, Dunn J, Nadle J, Lyons C, Beldavs ZG, Clark LA, Lessa FC. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States. J Clin Microbiol. 2014;52(2):632-4.
  • Wendt JM, Cohen JA, Mu Y, Dumyati GK, Dunn JR, Holzbauer SM, Winston LG, Johnston H, Meek JI, Farley MM, Wilson LE, Phipps EC, Beldavs ZG, Gerding DN, McDonald LC, Gould CV, Lessa FC. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics. 2014;133(4):651-8.
  • See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, Holzbauer S, Dunn JR, Farley MM, Lyons C, Johnston H, Phipps E, Perlmutter R, Anderson L, Gerding DN, Lessa FC. NAP1 strain type is a predictor of outcomes from Clostridium difficile infection. Clin Infect Dis 2014;58(10):1394-400.
  • Lessa FC, Mu Y, Winston L, Dumyati G, Farley MM, Beldavs Z, Kast K, Holzbauer SM, Meek JI, Cohen J, McDonald LC, Fridkin SK. Determinants of Clostridium difficile infection incidence across diverse U.S. geographic locations. Open Forum Infect Dis 2014;1(2):ofu048. doi: 10.1093/ofid/ofu048.
  • Rhee SM, Tsay R, Nelson DS, Wijngaarden E, Dumyati G. Clostridium difficile in the Pediatric Population of Monroe County, NY. J Ped Infect Dis 2014;3:183-8.
  • Lessa FC, Winston LG, McDonald LC; Emerging Infections Program C. difficile Surveillance Team. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372(24):2369-70.
  • Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LG, Less FC. Association between outpatient antibiotic prescribing practices and community-associated Clostridium difficile infection. Open Forum Infect Dis. 2015. doi: 10.1093/ofid/ofv113. First published online: August 11, 2015.
  • Baggs J, Yousey-Hindes K, Ashley ED, Meek J, Dumyati G, Cohen J, Wise ME, McDonald LC, Lessa FC. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. Vaccine. 2015 Nov 17;33(46):6241-9.
  • Hunter JC, Mu Y, Dumyati GK, Farley MM, Winston LG, Johnston HL, Meek JI, Perlmutter R, Holzbauer SM, Beldavs ZG, Phipps EC, Dunn JR, Cohen JA, Avillan J, Stone ND, Gerding DN, McDonald LC, Lessa FC. Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes. Open Forum Infect Dis. 2016 Jan 18;3(1):ofv196.

Healthcare-associated Infection – Community Interface (HAIC)

  • See I, Wesson P, Gualandi N, Dumyati G, Harrison L, Lesher L, Nadle J, Petit S, Reisenauer C, Schaffner W, Tunali A, Mu Y, Ahern J Socioeconomic factors explain racial disparities in community-associated invasive methicillin-resistant Staphylococcus aureus disease rates. Clin Infect Dis, 2017(64): 597-604.
  • Thompson ND, Wise M, Belflower R, Kanago M, Kainer MA, Lovell C, Patel PR Evaluation of Manual and Automated Bloodstream Infection Surveillance in Outpatient Dialysis Centers. Infect Control Hosp Epidemiol. 2016 Apr;37(4):472-4.
  • Epstein L, La Place L, Thompson D, Dumyati G, Concannon C, Quinlan G, Harper J, Warnke L, Lynfield R, Maloney M, Melchreit R, Stone ND, Thompson ND Comparison of Data Collection for Healthcare-associated Infection Surveillance in Nursing Homes ICHE 2016;37:1440–1445
  • Thompson N, LaPlace L, Epstein L, Dumyati G, Quinlan G, Concannon C, Thompson D, Melchreit R, Maloney M, Whitten T, Harper J, Lynfield R, Stone ND Prevalence of Antimicrobial Use and Opportunities to Improve Prescribing Practices in U.S. Nursing Homes Journal of the American Medical Directors Association
  • Epstein L, Mu Y, Belflower R, Scott J, Ray S, Dumyati G, et al. Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection after Recent Discahrge From An Acute-Care Hospitalization, 2011–2013. Clin Infect Dis.  2016;62(1):45-52
  • Nguyen DB, See I, Gualandi N, Shugart A, Lines C, Bamberg W, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Njord L, Sievert D, Thompson ND, Patel PR Completeness of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network, 2013 Infect Control Hosp Epidemiol. 2016 Feb;37(2):205-7.
  • Hunter JC, Mu Y, Dumyati GK, Farley MM, Winston LG, Johnston HL, Meek JI, Perlmutter R, Holzbauer SM, Beldavs ZG, Phipps EC, Dunn JR, Cohen JA, Avillan J, Stone ND, Gerding DN, McDonald LC, Lessa FC. Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes. Open Forum Infect Dis. 2016 Jan 18;3(1):ofv196.
  • Lockhart SR, Pham CD, Kuykendall RJ, Bolden CB, Cleveland A Candida lusitaniae MICs to the echinocandins are elevated but FKS-mediated resistance is rare. Microbiol Infect Dis. 2016;84:52-4.
  • Vallabhaneni S, Almendares O, Farley MM, Reno J, Smith ZT, Stein B, Magill SS, Smith RM, Cleveland AA, Lessa FC Epidemiology and factors associated with candidemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013. Epidemiol Infect. 2016;144(7):1440-4
  • Thompson ND, Edwards JR, Bamberg W, Beldavs Z, Dumyati G, Godine D, et al. Estimating central line-associated bloodstream infection incidence rates by sampling of denominator data: A prospective, multi-center evaluation. Am J Infect Control, Vol. 43, Issue 8, p853–856
  • Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, Wilson LE, Vaeth E, Lynfield R, Shaw KM, Vagnone PM, Bamberg WM, Janelle SJ, Dumyati G, Concannon C, Beldavs Z, Cunningham M, Cassidy PM, Phipps EC, Kenslow N, Travis T, Lonsway D, Rasheed JK, Limbago BM, Kallen AJ Epidemiology of Carbapenem-Resistant Enterobacteriaceae in Seven U.S. Communities, 2012-2013 2015 Oct 13;314(14):1479-87.
  • Chea N, Bulens SN, Kongphet-Tran T, Lynfield R, Shaw KM, Vagnone PM, et al An Evaluation of Phenotypic Definitions for the Identification of Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae. Emerg Infect Dis. 2015 Sep;21(9):1611-6.
  • Fridkin SK, Cleveland AA, See I, Lynfield Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance. Emerg Infect Dis. 2015 Sep;21(9):1578-81.
  • Magill SS, Dumyati G, Ray SM, Fridkin S Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States. Emerg Infect Dis. 2015 Sep;21(9):1537-42.
  • Baggs J, Yousey-Hindes K, Ashley ED, Meek J, Dumyati G, Cohen J, Wise ME, McDonald LC, Lessa FC Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. Vaccine. 2015 Nov 17;33(46):6241-9.
  • Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC. Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113.
  • Grossman NT, Pham CD, Cleveland AA, Lockhart S Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system Antimicrob Agents. Chemother 2015;59:1030-7.
  • Cleveland AA, et a Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two U.S. metropolitan areas, 2008-2013: results from population-based surveillance PLoS ONE. 2015;10(3):e0120452.
  • Vallabhaneni S, Cleveland AA, Farley MM, Harrison LH, Schaffner W, Beldavs ZG, Derado G, Pham CD, Lockhart SR, Smith RM Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014. Open Forum Infect Dis. 2015;2(4):ofv163.
  • Reno J, Doshi SS, Scott J, Stein B, Farley MM, Ray S, Jacob JT. Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Co-infections among Adults with Candidemia in Atlanta, GA, 2008-2012. Infect Control Hosp Epidemiol. 2015 Nov;36(11):1298-304.
  • Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al Burden of Clostridium difficile infection in the United States  N Engl J Med 2015;372:825-34.
  • Pham CD, Iqbal N, Bolden CB, Kuykendall RJ, Harrison LH, Farley MM, et a Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance. Antimicrob Agents Chemother 2014;58:4960-6.
  • Pham CD, Bolden CB, Kuykdendall R, Lockhart S Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to echinocandins in Candida glabrata. J Clin Microbiol 2014;52:790-5.
  • Lockhart S Current epidemiology of Candida infection Clin Microbiol Newsletter 2014;36:131-6.
  • Grossman NT, Chiller TM, Lockhart S Epidemiology of echinocandin resistance in Candida Curr Fungal Infect Rep 2014;8:243-8.
  • Cohen J, Limbago L, Dumyati G, Holzbauer S, Johnston H, Perlmutter R, Dunn J, Nadle J, Lyons C, Beldavs ZG, Clark LA, Lessa FC. Impact of Changes in Clostridium difficile Testing Practices on Stool Rejection Policies and C. difficile Positivity Rates across Multiple Laboratories in the United States.  J Clin Microbiol. 2014;52(2):632-4.
  • Wendt JM, Cohen JA, Mu Y, Dumyati GK, Dunn JR, Holzbauer SM, Winston LG, Johnston H, Meek JI, Farley MM, Wilson LE, Phipps EC, Beldavs ZG, Gerding DN, McDonald LC, Gould CV, Lessa FC. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics. 2014 Apr;133(4):651-8.
  • See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, Holzbauer S, Dunn JR, Farley MM, Lyons C, Johnston H, Phipps E, Perlmutter R, Anderson L, Gerding DN, Lessa FC. NAP1 Strain Type Is a Predictor of Outcomes from Clostridium difficile Infection. Clin Infect Dis 2014 May;58(10):1394-400.
  • Meek JI, Cohen J, McDonald LC, Fridkin SK. Determinants of Clostridium difficile Infection Incidence Across Diverse U.S. Geographic Locations. Open Forum Infect Dis 2014; doi: 10.1093/ofid/ofu048.
  • Rhee SM, Tsay R, Nelson DS, Wijngaarden E, Dumyati Clostridium difficile in the Pediatric Population of Monroe County, NY J Ped Infect Dis 2014;3:183-8.
  • Lessa FC, Mu Y, Winston LG, Dumyati GK, Farley MM, Beldavs ZG, Kast K, Holzbauer SM, Meek JI, Cohen J, McDonald LC, Fridkin SK Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations. Open Forum Infect Dis. 2014 Jul 28;1(2):ofu048.
  • Reno J, Schenck C, Scott J, Clark LA, Wang W, Ray S, Vagnone P, Jacob JT Querying Automated Antibiotic Susceptibility Testing Instruments: A Novel Population-Based Active Surveillance Method for Multidrug Resistant Gram Negative Bacilli. Infection Control and Hospital Epidemiology. April 2014;35(4).
  • Shaw K, Harper JE, Vagnone PM, Lynfield R Establishing Surveillance for Carbapenem-resistant Enterobacteriaceae in Minnesota, 2012. Infection Control and Hospital Epidemiology. April 2014;35(4).
  • Pereira EC, Shaw KM, Vagnone PM, Harper JE, Kallen AJ, Limbago BM, Lynfield R Thirty-day laboratory-based surveillance for carbapenem-resistant Enterobacteriaceae in the Minneapolis-St. Paul metropolitan area. Infection Control and Hospital Epidemiology April 2014;35(4).
  • Pfeiffer CD, Cunningham MC, Poissant T, Furuno JP, Townes JM, Leitz A, Thomas A, Buser GL, Arao RF, Beldavs ZG. Establishment of a Statewide Network for Carbapenem-Resistant Enterobacteriaceae. Infection Control and Hospital Epidemiology. April 2014;35(4).
  • Magill SS, Edwards JR, Bamberg W, Beldavs Z, Dumyati G, Kainer M, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK. Multistate point prevalence survey of healthcare associated infections. N Engl J Med 2014 Mar 27;370(13):1198-208.
  • Magill SS, Edwards JR, Janelle S, Beldavs Z, Dumyati G, Kainer M, Lynfield R, Maloney M, Neuhauser M, Nadle J, Ray SM, Thompson DL, Richards K, Fridkin SK Prevalence of antimicrobial use in acute care hospitals. JAMA 2014;312:1438-46.
  • CDC Antibiotic resistant threats in the United States, 2013 Cdc-pdf[PDF – 114 pages] Centers for Disease Control and Prevention.
  • Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Beldavs ZG, Dunn JR, Gould LH, MacCannell DR, Gerding DN, McDonald LC, Lessa FC Epidemiology of community-associated Clostridium difficile infection, 2009–2011 JAMA Intern Med 2013;173:1359-67.
  • Gould CV, Edwards JR, Cohen J, Bamberg WM, Clark LA, Farley MM, Johnston H, Nadle J, Winston L, Gerding DN, McDonald LC, Lessa FC   Effect of Nucleic Acid Amplification Testing on Population-based Incidence Rates of Clostridium difficile Infection. Clinical Infectious Diseases 2013; doi: 10.1093/cid/cit492.
  • CDC Antibiotic resistance threats in the United States, 2013.
  • Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Beldavs Z, Dunn JR, Gould LH, MacCannell DR, Gerding DN, McDonald LC, Lessa FC. Epidemiology of community-associated Clostridium difficile infection, 2009–2011.  JAMA Intern Med. 2013;173(14):1359-1367. doi:10.1001/jamainternmed.2013.7056.
  • Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S. Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173(21):1970-8.
  • Duffy J, Dumyati G, Bulens S, Namburi S, Gellert A, Fridkin SK, Lessa FC. Community-Onset Invasive Methicillin-Resistant Staphylococcus aureus Infections Following Hospital Discharge. Am J Infect Control. 2013;41(9):782-6.
  • Iwamoto, M, Mu Y, Lynfield R, Bulens SN, Nadle J, Aragon D, Petit S, Ray SM, Harrison LH, Dumyati Gi, Townes JM, Schaffner W, Gorwitz RJ, Lessa FC. Trends in Invasive Methicillin-Resistant Staphylococcus aureus Infections. Pediatrics. 2013;132(40):e817-24.
  • Nguyen DB, Lessa FC, Belflower R, Mu Y, Wise M, Nadle J, Bamberg WM, Petit S, Ray SM, Harrison LH, Lynfield R, Dumyati G, Thompson J, Schaffner W, Paterl PR, for the Active Bacterial Core Surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Chronic Dialysis Patients in the United States, 2005–2011.  Clin Infect Dis. 2013;57:1393–400.
  • Tosh PK, Bulens SN, Nadle J, Dumyati G, Lynfield R, Schaffner W, Ray S, Seema J, Fridkin SK, Sievert DM. Characterization of Hospitalized Community-Onset Staphylococcus aureus Lower Respiratory Tract Infections Among Generally Healthy Persons 50 Years of Age or Younger. Infect Dis Clin Prac. 2013;21:359-65.
  • CDC Vital signs: Carbapenem-Resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013 Mar 5;62(9):1-6.
  • Thompson ND, Edwards J, Bamberg W, Beldavs Z, Dumyati G, Godine D, Ray S, Thompson D, Wilson L, Magill S Evaluating the accuracy of sampling to estimate central line days: Simplification of the National Healthcare Safety Network surveillance methods. Infect Control Hosp Epidemiol 2013;33:221-8.
  • Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, Magill SS, Derado G, Park BJ, and Chiller TM Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clinical Infectious Diseases 2012; 55:1352-61.
  • Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, and Chiller TM Species identification and antifungal susceptibility of Candida bloodstream isolates from population-based surveillance in two U.S. cities: 2008-2011 J Clin Microbiol 2012;50:3435-42.
  • Pawar D, Tsay R, Nelson DS, Elumalai MK, Lessa FC, Clifford McDonald L, Dumyati Burden of Clostridium difficile Infection in Long-Term Care Facilities in Monroe County, New York. Infect Control Hosp Epidemiol. 2012 Nov;33(11):1107-12.
  • Centers for Disease Control and Prevention (CDC) Vital Signs: Preventing Clostridium difficile infections MMWR Morb Mortal Wkly Rep. 2012 Mar 9;61(9):157-62.
  • Pawar D, Tsay R, Nelson DS, Elumalai MK, Lessa FC, Clifford McDonald L, Dumyati G. Burden of Clostridium difficile Infection in Long-Term Care Facilities in Monroe County, New York. Infect Control Hosp Epidemiol. 2012 Nov;33(11):1107-12.
  • Centers for Disease Control and Prevention (CDC) Vital Signs: Preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012 Mar 9;61(9):157-62.
  • Bender JB, Waters KC, Nerby J, Olsen KE, Jawahir S. Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated From Pets Living in Households with MRSA-Infected Children. Clin Infect Dis. February 2012; 54(3):449-50.
  • Hadler JL, Petit S, Mandour M, Cartter ML. Trends in Invasive Infections with Methicillin-Resistant Staphylococcus aureus, Connecticut, 2001–2010. Emerg Infect Dis. 2012 June; 18(6):907–927.
  • Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, Devries A, Schaffner W, Nadle J, Gershman K, Fridkin SK for the Active Bacterial Core surveillance (ABCs) Investigators of the Emerging Infections Program. Impact of USA300 Methicillin-Resistant Staphylococcus aureus on Clinical Outcomes of Patients with Penumonia or Central Line-Associated Bloodstream Infections. Clin Infect Dis. 2012 Jul; 55(2):232-41.
  • See I, Iwamoto M, Allen-Bridson K, Horan T, Magill S, Thompson N and the MBI-LCBI Field Test Working Group. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infection: Results from Field Test of a New National Healthcare Safety Network Definition. Infect Control Hosp Epidemiol. 2012;34:769-76.

Invasive Staphylococcus aureus (MRSA/MSSA)

  • Johnson NB, Hayes LD, Hoo EC, Ethier KA. CDC National Health Report: Leading causes of morbidity and mortality and associated risk and protective factors – United States, 2005-2013. MMWR Supplements 2014; 63(04):3-27.
  • Nguyen DB, See I, Gualandi N, et al. Completeness of MRSA bloodstream infection reporting from outpatient hemodialysis facilities to the national healthcare safety network, 2013. Infect Control Hosp Epidemiol. 2016 Feb;37(2):205-7.
  • Epstein L, Mu Y, Belflower R, Scott J, Ray S, Dumyati G, et al. Risk factors for invasive methicillin-resistant Staphylococcus aureus infection after recent discharge from an acute-care hospitalization, 2011-2013. Clin Infect Dis. 2016;62(1):45-52.
  • Reno J, Doshi S, Tunali AK, Stein B, Farley MM, Ray SM, Jacob JT. Epidemiology of methicillin-resistant Staphylococcus aureus bloodstream co-infection among adults with candidemia in Atlanta, GA, 2008-2012. Infect Control Hosp Epidemiol. 2015 Nov;36(11):1298-304.
  • Fridkin SK, Cleveland AA, See I, Lynfield R. Emerging Infections Program as surveillance for antimicrobial drug resistance. Emerg Infect Dis. 2015 Sep;21(9):1578-1581.
  • Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S. Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173(21):1970-8.
  • Duffy J, Dumyati G, Bulens S, Namburi S, Gellert A, Fridkin SK, Lessa FC. Community-onset invasive methicillin-resistant Staphylococcus aureus infections following hospital discharge. Am J Infect Control. 2013;41(9):782-6.
  • Iwamoto M, Mu Y, Lynfield R, Bulens, SN, Nadle J, Aragon D, Petit S, Ray SM, Harrison LH, Dumyati G, Townes JM, Schaffner W, Gorwitz RJ, Lessa FC. Trends in invasive methicillin-resistant Staphylococcus aureus infections. Pediatrics. 2013;132(40):e817-24.
  • Nguyen DB, Lessa FC, Belflower R, Mu Y, Wise M, Nadle J, Bamberg WM, Petit S, Ray SM, Harrison LH, Lynfield R, Dumyati G, Thompson J, Schaffner W, Patel PR; for the Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Invasive methicillin-resistant Staphylococcus aureus infections among chronic dialysis patients in the United States, 2005-2011. Clin Infect Dis. 2013;57:1393-400.
  • Tosh PK, Bulens SN, Nadle J, Dumyati G, Lynfield R, Schaffner W, Ray S, Seema J, Fridkin SK, Sievert DM. Characterization of hospitalized community-onset Staphylococcus aureus lower respiratory tract infections among generally healthy persons 50 years of age or younger. Infect Dis Clin Prac.2013;21:359-65.
  • Bender JB, Waters KC, Nerby J, Olsen KE, Jawahir S. Methicillin-resistant Staphylococcus aureus (MRSA) isolated from pets living in households with MRSA-infected children. Clin Infect Dis. February 2012;54(3):449-50.
  • Hadler JL, Petit S, Mandour M, Cartter ML. Trends in Invasive Infection with methicillin-resistant Staphylococcus aureus, Connecticut, 2001-2010. Emerg Infect Dis. 2012 June; 18(6):917-924.
  • Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, Devries A, Schaffner W, Nadle J, Gershman K, Fridkin SK for the Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections. Clin Infect Dis. 2012 Jul; 55(2): 232-41.
  • CDC. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2011Cdc-pdf[PDF – 340 KB].
  • DeVries A, Lesher L, Schlievert PM, Rogers T, Gomez-Villaume L, Danila R, et al. Staphylococcal toxic shock syndrome 2000-2006: Epidemiology, clinical features, and molecular characteristics. PLoS One. 2011: 6(8):e22997.
  • Nerby JM, Gorwitz R, Lesher L, Juni B, Jawahir S, Lynfield R, Harriman K. Risk factors for household transmission of community-associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2011;30(11):927-932.
  • Satola SW, Lessa FC, Ray SM, Bulens SN, Lynfield R, Schaffner W, Dumyati G, Nadle J, Patel JB. Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: Lack of effect of heteroresistant vancomycin-intermediate S. aureus phenotype. J Clin Microbiol. 2011;49(4):1583-87.
  • Satola SW, Farley MM, Anderson KF, Patel JB. Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol. 2011;49(1):177-83.
  • CDC. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2010Cdc-pdf[PDF – 342 KB].
  • Como-Sabetti KJ, Harriman KH, Fridkin SK, Jawahir SL, Lynfield R. Risk factors for community-associated Staphylococcus aureus infections: Results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls. Epidemiol Infect. 2010;1:1-11.
  • Kallen A, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, DumyatiG, Townes JM, Schaffner W, Patel PR, Fridkin SK for the Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Healthcare-associated invasive MRSA infections, 2005-2008. JAMA 2010; 304(6):641-48.
  • Kempker RR, Farley MM, Ladson JL, Satola S, Ray SM. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA Bacteremia. J Infect. 2010;61:372-81.
  • Lessa FC, Mu Y, Davies J, Murray M, Lillie M, Pearson A, Fridkin S for the Emerging Infections Program/Active Bacterial Core surveillance MRSA investigators and the Health Protection Agency Team. Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006-2007. Clin Infect Dis 2010;51(8):925-28.
  • Shukla SK, Karow ME, Brady JM, Stemper ME, Kislow J, Moore N, Wroblewski K, Chyou PH, Warshauer DM, Reed KD, Lynfield R, Schwan WR. Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates. J Clin Microbiol. 2010;48(10):3582-92.
  • CDC. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2009Cdc-pdf[PDF -337 KB].
  • Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, Heltzel D, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Mu Y, Fridkin SK. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 2009;47(5):1344-51.
  • Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Fridkin SK for ABCs MRSA Investigators. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through the use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States. Vaccine 2009;27(37):5061-68.
  • Buck JM, Harriman KH, Juni BA, Gall K, Boxrud DJ, Glennen A, Danila R, Lynfield R. No change in methicillin-resistant Staphylococcus aureus nasal colonization rates among Minnesota school children during 2 study periods. Infect Dis Clin Pract 2008;16(3):163-5.
  • CDC. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2008.
  • Tenover FC, McAllister S, Fosheim G, McDougal LK, Carey RB, Limbago B, Lonsway D, Patel JB, Kuehnert MJ, Gorwitz R. Characterization of Staphylococcus aureus Isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J Clin Microbiol 2008;46(9):2837-41.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2007.
  • Klevens MR, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK for ABCs MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298(15):1763-71.
  • CDC. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2006.
  • Klevens MR, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati R, Townes JM, Craig AS, Fosheim G, McDougal LK, Tenover FC, for ABCs/EIP. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infec Dis 2006;12:1991-3.
  • CDC. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2005.
  • Buck JM, Como-Sabetti K, Harriman KH, Danila RN, Boxrud DJ, Glennen A, Lynfield R. Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003. Emerg Infect Dis. 2005; 11(10):1532-8.
  • Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM for the Active Bacterial Core Surveillance Program of The Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44.
  • Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O’Boyle C, Danila RN,
    Lynfield R. Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-84.
  • Morin C, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in four metropolitan areas in Connecticut, 1998. J Infect Dis 2001;184:1029-34.

Multi-site Gram-negative Surveillance Initiative (MuGSI)

 Top of Page
 Top of Page
Page last reviewed: October 15, 2018
Content source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Preparedness and Emerging Infections (DPEI)